Febuxostat for Cerebral and caRdiorenovascular Events prEvEntion stuDy
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate the effect of febuxostat in preventing cerebral
and cardiorenovascular events in elderly patients with hyperuricemia who are at risk for
cerebral and cardiorenovascular disease.